Idiopathic pulmonary fibrosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals aged 16 years or older at the time of obtaining informed consent. 2. Individuals who are suspected of having or have been diagnosed with idiopathic pulmonary fibrosis. 3. Individuals who have received sufficient explanation about the study and have provided written informed consent of their own free will.
Exclusion criteria
Exclusion criteria: Individuals who are judged by the principal investigator to be inappropriate for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Examination of senescence-associated glycoprotein (SAGP) expression in lung tissue assessed in patients undergoing diagnostic lung biopsy | — |
Secondary
| Measure | Time frame |
|---|---|
| Circulating SAGP level at the time of sample collection after informed consent Association between circulating SAGP levels and pulmonary function parameters (VC, FVC, DLco) Association between circulating SAGP levels and established biomarkers (KL-6, SP-D, proBNP) Association between circulating SAGP levels and DNA methylation profiles | — |
Countries
Japan
Contacts
Juntendo University Hospital Department of Cardiovascular Biology and Medicine